Clinical Trials on Lysosomal Storage Diseases, Nervous System
Total 194127 results
-
TakedaCompleted
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseCanada, Russian Federation, Tunisia
-
ShireCompleted
-
PfizerCompletedGaucher DiseaseUnited Kingdom, Canada, Israel, United States, Australia, Spain
-
PfizerCompletedGaucher DiseaseChile, United Kingdom, Canada, Spain, Israel, United States, Australia, South Africa
-
PfizerCompletedGaucher DiseaseIsrael, Paraguay, South Africa
-
Yasmeen Abd Elbaset HamzaaUnknownGaucher Disease
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States, Sweden, India, Netherlands, Austria, Japan, China, Serbia, France, Croatia, Australia, Portugal, Canada, Brazil, Greece, Romania, Russian Federation
-
ISU Abxis Co., Ltd.Completed
-
National Human Genome Research Institute (NHGRI)Sio Gene TherapiesRecruitingGangliosidosis | Lysosomal Diseases | GM1United States
-
National Institute of Neurological Disorders and...Completed
-
University of MinnesotaRecruitingGaucher Disease, Type 3United States
-
TakedaActive, not recruiting
-
Shaare Zedek Medical CenterShireCompletedGaucher Disease, Type 1
-
Shaare Zedek Medical CenterPfizerCompletedGaucher Disease, Type 1
-
National Taiwan University HospitalSanofiCompleted
-
ShireCompletedGaucher Disease, Type 1Israel, Paraguay, Argentina, Russian Federation, Tunisia
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
PfizerWithdrawnType 1 Gaucher DiseaseUnited States
-
National Taiwan University HospitalActelionUnknown
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
National Institute of Neurological Disorders and...CompletedType 2 Gaucher DiseaseUnited States
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
University of AarhusUnknownGlycogen Storage Disease Type 2 | Dystrophia MyotonicaDenmark
-
University Hospital Center of MartiniqueRecruiting
-
University of California, IrvineCompletedMuscle Weakness | Pompe DiseaseUnited States
-
National Institute of Neurological Disorders and...CompletedGaucher DiseaseUnited States
-
SanofiCompletedGaucher's DiseaseUnited States
-
ShireCompletedGaucher DiseaseUnited States, Spain, United Kingdom, Israel
-
ShireCompletedGaucher DiseaseIsrael, Romania, Serbia
-
ShireCompletedGaucher Disease, Type 3Egypt, India, Tunisia
-
ISU Abxis Co., Ltd.CompletedGaucher Disease, Type 1
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, France, Germany, Italy, Brazil, Australia, Argentina, Canada, Egypt, Russian Federation, Spain, United Kingdom
-
Genzyme, a Sanofi CompanyWithdrawnGaucher Disease, Type 1United States, India
-
ISU Abxis Co., Ltd.Completed
-
Amicus TherapeuticsTerminatedType 1 Gaucher DiseaseUnited States, United Kingdom
-
Xinhua Hospital, Shanghai Jiao Tong University...Shanghai Vitalgen BioPharma Co., Ltd.RecruitingType II Gaucher DiseaseChina
-
Prevail TherapeuticsEli Lilly and CompanyRecruitingGaucher Disease | Gaucher Disease, Type 1United States, Spain, Germany
-
Shaare Zedek Medical CenterRecruiting
-
Prevail TherapeuticsEli Lilly and CompanyActive, not recruitingGaucher Disease, Type 2United States, United Kingdom
-
AVROBIOTerminatedGaucher DiseaseUnited States, Canada
-
SanofiCompletedGaucher's DiseaseUnited States
-
Hadassah Medical OrganizationCompleted
-
AVROBIOTerminatedType 1 Gaucher DiseaseUnited States, Canada
-
Shaare Zedek Medical CenterCompletedGaucher Disease, Type 1Israel
-
Ari ZimranPfizerActive, not recruitingGaucher Disease, Type 3Israel, Turkey, India
-
CEN BiotechTakeda; BioClinica, Inc.Completed